Symptoms of Primary Ocular Lymphoma (Lymphoma of the Eye)

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid tissue (MALT). The eye is a fairly rare place to get lymphoma but it does happen. The medical term for this is an Extranodal Lymphoma as it arises outside the lymph nodes.

Non Hodgkin's lymphoma can start in the eye. It is called ocular lymphoma when it did not start elsewhere including the central nervous system (CNS) (brain etc.) These lymphomas are all quite rare. Isolated ocular lymphoma apparently is increasing in frequency, maybe due to occurrence in some AIDS patients. It represents a difficult extranodal site to treat.

Ocular lymphomas should not be confused with other cancers that can might strike the eye or related tissue or spread to the eye from another location.

Symptoms

The most common presenting ocular symptoms are blurred vision and floaters. Pain and conjunctival hyperemia (engorgement of blood vessels around the eye) are rare. Vision is often decreased. Biomicroscopic exam often shows mild anterior segment inflammation with cells and flare and keratic precipitates. Vitreous cells occurring in sheets are characteristic. Although the disease may begin with one eye, bilateral (both eye) involvement is common after several months.

Doctors may look for Interleukin-10, a growth and differentiation factor for B lymphocytes to determine if the condition is lymphoma instead of another eye condition which may be attracting lymphocytes such as an infection. A recent 2004 study suggests that CDR3 polymorphism analysis is recommended to confirm clonality.

Treatment

The disease treatment may include external beam radiation, chemotherapy, or both.

Radioimmunotherapy regimens such as Zevalin show promising results in clinical trials for many types of B-cell NHLs.

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap